<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal CancerChristos S. Karapetis, John Zalcberg, Heather‐Jane Au et al.|New England Journal of Medicine|2008Cited by 3.6k
Cetuximab for the Treatment of Colorectal CancerDerek J. Jonker, Malcolm J. Moore, Chris J. O’Callaghan et al.|New England Journal of Medicine|2007Cited by 1.8k
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized TrialsEmmanuel Mitry, Philippe Rougier, Anthony Fields et al.|Journal of Clinical Oncology|2008Cited by 582
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal CancerEric X. Chen, Chris J. O’Callaghan|JAMA Oncology|2020Cited by 389
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17Stephanie Yasmin Brule, Rachel Goodwin, Christos S. Karapetis et al.|European Journal of Cancer|2015Cited by 337